425: Strive, Semler Scientific Merger Communication & Risks

Strive, Inc. reposts a communication on X.com regarding its proposed business combination with Semler Scientific, Inc., including cautionary forward-looking statements.

Summary

• A communication was reposted on X.com by Logan Beirne, Chief Legal Officer of Strive, Inc., on November 10, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc.
• It includes a cautionary statement regarding forward-looking statements, defining them and outlining inherent risks and uncertainties.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus when available for important information.
• Strive, Semler Scientific, and certain of their respective directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication explicitly states it is not an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a procedural update and a cautionary statement regarding a proposed merger. While the merger itself implies potential positive outcomes, the document's primary focus is on outlining numerous risks and uncertainties associated with forward-looking statements and the transaction, leading to a neutral to slightly cautious sentiment.

Positives

• The proposed transaction is expected to yield strategic benefits and financial benefits, including a positive impact on the combined company's future financial performance.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Forward-looking statements indicate expectations regarding the proposed transaction, including its strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the combined businesses. However, these statements are subject to inherent risks and uncertainties, and actual results may differ materially from anticipated outcomes.

Management Comments

• Logan Beirne, Chief Legal Officer of Strive, Inc., reposted the communication on X.com.

Industry Context

This announcement is specific to the proposed business combination between Strive, Inc. and Semler Scientific, Inc., and does not provide broader industry context or trends.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Changes to business or employee relationships.
• Dilution for Strive's shareholders due to the issuance of additional Class A common stock.
• Impact on stockholders of Semler Scientific who will vote on the proposed transaction.

Next Steps

• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, as well as any other relevant documents filed with the SEC.

Key Dates

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, forward-looking statements, risk factors, corporate governance, Bitcoin treasury, digital assets, proxy solicitation